SCHEMBL14748788

SCHEMBL14748788

c1ccc(-c2ccc(-c3ccc(-n4c5ccccc5c5ccc(-c6ccc7c8ccccc8n(-c8cccc(-c9nc(-c%10ccccc%10)cc(-c%10ccccc%10)n9)c8)c7c6)cc54)cc3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ ATM Q13315 1/20 0.45
▸ MEN1 O00255 6/20 0.40
▸ KMT2A Q03164 6/20 0.40
▸ MAPT P10636 5/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ HPGD P15428 4/20 0.40
▸ LMNA P02545 2/20 0.40
▸ NTSR1 P30989 1/20 0.39
▸ GLA P06280 1/20 0.38
▸ HDAC4 P56524 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.35
▸ AVPR1A P37288 1/20 0.35
▸ DHODH Q02127 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ ADORA2A P29274 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14748765 1.00 KDM4E (0.45) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL19774429 0.99 KDM4E (0.44) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL15197777 0.99 KDM4E (0.46) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL17714948 0.97 KDM4E (0.45) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL14748849 0.97 KDM4E (0.45) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL19862593 0.97 KDM4E (0.45) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL14748773 0.97 KDM4E (0.45) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL14748767 0.97 KDM4E (0.47) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL14748785 0.97 KDM4E (0.44) KDM4EL3MBTL1ATMMEN1KMT2A
SCHEMBL14748942 0.96 KDM4E (0.42) KDM4EL3MBTL1ATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9543530-B2 Compound for organic optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode CHEIL INDUSTRIES, INC. (KR) 2017-01-10 — — US disclosed
US-9543530-B2 Compound for organic optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode CHEIL INDUSTRIES, INC. (KR) 2017-01-10 — — US disclosed
US-20150021585-A1 COMPOSITION FOR ORGANIC LIGHT-EMITTING DIODE, ORGANIC LIGHT-EMITTING LAYER INCLUDING SAME, AND ORGANIC LIGHT-EMITTING DIODE SAMSUNG SDI CO., LTD. (KR) 2015-01-22 — — US disclosed
US-20150021585-A1 COMPOSITION FOR ORGANIC LIGHT-EMITTING DIODE, ORGANIC LIGHT-EMITTING LAYER INCLUDING SAME, AND ORGANIC LIGHT-EMITTING DIODE SAMSUNG SDI CO., LTD. (KR) 2015-01-22 — — US disclosed
US-20130056720-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2013-03-07 — — US disclosed
US-20130056720-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2013-03-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130056720-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE AOX1, PPOX, OR51E2 KDM4E 2263/4885L3MBTL1 1130/4885ATM 4552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback